Literature DB >> 6165889

Acquired vitamin K-dependent carboxylation deficiency in liver disease.

R A Blanchard, B C Furie, M Jorgensen, S F Kruger, B Furie.   

Abstract

gamma-Carboxyglutamic acid residues on prothrombin are synthesized from glutamic acid on a prothrombin precursor in the liver through a vitamin K-dependent carboxylase. In the absence of vitamin K or in the presence of vitamin K antagonists, an inert form of prothrombin - abnormal prothrombin - circulates in the blood. We have developed specific immunoassays for native and abnormal human prothrombin. The prothrombin concentration in our normal subjects was 108 +/- 19 microgram per milliliter. The abnormal-prothrombin concentration varied over four orders of magnitude between the limits of detection in normal plasma and the level in patients with cirrhosis (0 to 5 microgram per milliliter), acute hepatitis (0 to 33 microgram per milliliter), or vitamin K deficiency (32 to 100 microgram per milliliter) and in those treated with sodium warfarin (12 to 65 microgram per milliliter). These studies indicate that abnormal prothrombin is not a component of normal plasma but appears in a variety of hepatic and nutritional disorders characterized by impaired hepatic vitamin-K-dependent carboxylation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165889     DOI: 10.1056/NEJM198107303050502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  16 in total

Review 1.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

Review 2.  Haemostatic problems in liver disease.

Authors:  D A Kelly; E G Tuddenham
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

Review 3.  Screening for hepatocellular carcinoma. Review and perspective.

Authors:  J C Ellis
Journal:  West J Med       Date:  1988-08

Review 4.  Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?

Authors:  Margaret Spinosa; Jonathan G Stine
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

5.  Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex.

Authors:  H A Liebman; S A Limentani; B C Furie; B Furie
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Abnormal plasma prothrombin (PIVKA-II) levels in hepatocellular carcinoma.

Authors:  Y Kawaguchi
Journal:  Jpn J Surg       Date:  1989-05

7.  Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors.

Authors:  G H Goldsmith; R E Pence; O D Ratnoff; D J Adelstein; B Furie
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

8.  Lymphoid procoagulant response to bacterial endotoxin in the rat.

Authors:  P A Lando; T S Edgington
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor.

Authors:  D L Diuguid; M J Rabiet; B C Furie; H A Liebman; B Furie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

10.  Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives.

Authors:  R M Pauli; J B Lian; D F Mosher; J W Suttie
Journal:  Am J Hum Genet       Date:  1987-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.